A detailed history of Campbell & CO Investment Adviser LLC transactions in Xencor Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 24,363 shares of XNCR stock, worth $562,054. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,363
Holding current value
$562,054
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.7 - $21.65 $382,499 - $527,458
24,363 New
24,363 $489,000
Q4 2023

Feb 13, 2024

BUY
$16.53 - $21.42 $175,118 - $226,923
10,594 New
10,594 $224,000
Q3 2021

Nov 10, 2021

SELL
$30.65 - $35.68 $357,777 - $416,492
-11,673 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$34.33 - $44.68 $400,734 - $521,549
11,673 New
11,673 $403,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.